Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?
Expert Rev Clin Pharmacol. 2023 Aug 14. doi: 10.1080/17512433.2023.2247977. Online ahead of print.NO ABSTRACTPMID:37577977 | DOI:10.1080/17512433.2023.2247977
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Theocharis Koufakis Michael N Doumas Alexandra Bargiota Kalliopi Kotsa Giuseppe Maltese Source Type: research
More News: Cardiology | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart | Heart Failure | Malta Health | Sodium